Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.
Stieglmaier J, Bremer E, Kellner C, Liebig TM, ten Cate B, Peipp M, Schulze-Koops H, Pfeiffer M, Bühring HJ, Greil J, Oduncu F, Emmerich B, Fey GH, Helfrich W. Stieglmaier J, et al. Among authors: buhring hj. Cancer Immunol Immunother. 2008 Feb;57(2):233-46. doi: 10.1007/s00262-007-0370-8. Epub 2007 Jul 31. Cancer Immunol Immunother. 2008. PMID: 17665197 Free PMC article.
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.
Mehta NK, Pfluegler M, Meetze K, Li B, Sindel I, Vogt F, Marklin M, Heitmann JS, Kauer J, Osburg L, Zekri L, Bühring HJ, Mueller S, Hörner S, Baeuerle PA, Michaelson JS, Jung G, Salih HR. Mehta NK, et al. Among authors: buhring hj. J Immunother Cancer. 2022 Mar;10(3):e003882. doi: 10.1136/jitc-2021-003882. J Immunother Cancer. 2022. PMID: 35288466 Free PMC article.
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer.
Neumann A, Hörzer H, Hillen N, Klingel K, Schmid-Horch B, Bühring HJ, Rammensee HG, Aebert H, Stevanović S. Neumann A, et al. Among authors: buhring hj. Cancer Immunol Immunother. 2013 Sep;62(9):1485-97. doi: 10.1007/s00262-013-1454-2. Epub 2013 Jul 2. Cancer Immunol Immunother. 2013. PMID: 23817722 Free PMC article.
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, Bischof F, Bühring HJ, Dichgans J, Rammensee HG, Steinle A, Weller M. Friese MA, et al. Among authors: buhring hj. Cancer Res. 2003 Dec 15;63(24):8996-9006. Cancer Res. 2003. PMID: 14695218
CDCP1 is a novel marker for hematopoietic stem cells.
Conze T, Lammers R, Kuci S, Scherl-Mostageer M, Schweifer N, Kanz L, Buhring HJ. Conze T, et al. Among authors: buhring hj. Ann N Y Acad Sci. 2003 May;996:222-6. doi: 10.1111/j.1749-6632.2003.tb03249.x. Ann N Y Acad Sci. 2003. PMID: 12799299
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Schilbach K, Kerst G, Walter S, Eyrich M, Wernet D, Handgretinger R, Xie W, Rammensee HG, Müller I, Bühring HJ, Niethammer D. Schilbach K, et al. Among authors: buhring hj. Blood. 2005 Jul 1;106(1):144-9. doi: 10.1182/blood-2004-07-2940. Epub 2005 Feb 24. Blood. 2005. PMID: 15731181 Free article.
196 results